Rockwell Medical (RMTI) Intangibles (2010 - 2026)
Rockwell Medical (RMTI) posted Intangibles of $9.5 million for Q1 2026, down 1.43% on a QoQ basis from $9.7 million in Q4 2025, and down 5.47% year-over-year from $10.1 million in Q1 2025.
Rockwell Medical (RMTI) Intangibles (2010 - 2026) Analysis & Trends
Rockwell Medical's Intangibles history runs 13 years deep, the most recent figure standing at $9.5 million for Q1 2026.
- Quarterly Intangibles fell 5.47% year-over-year to $9.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.5 million (down 5.47% YoY) and the FY2025 annual result came in at $9.7 million, down 5.4% from the prior year.
- Intangibles was $9.5 million for Q1 2026 at Rockwell Medical, down from $9.7 million in the prior quarter.
- Across five years, Intangibles topped out at $10.9 million in Q3 2023 and bottomed at $9.5 million in Q1 2026.
- A 4-year average of $10.2 million and a median of $10.2 million in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2024 — Intangibles slipped 5.07% — and 2026, when it retreated 5.47%.
- Rockwell Medical's Intangibles stood at $10.8 million in 2023, then declined by 5.13% to $10.2 million in 2024, then declined by 5.4% to $9.7 million in 2025, then slipped by 1.43% to $9.5 million in 2026.
- Business Quant data shows RMTI's Intangibles at $9.5 million in Q1 2026, $9.7 million in Q4 2025, and $9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 9.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.52 Mn |
| Dec 31, 2025 | 9.66 Mn |
| Sep 30, 2025 | 9.79 Mn |
| Jun 30, 2025 | 9.93 Mn |
| Mar 31, 2025 | 10.07 Mn |
| Dec 31, 2024 | 10.21 Mn |
| Sep 30, 2024 | 10.35 Mn |
| Jun 30, 2024 | 10.48 Mn |
| Mar 31, 2024 | 10.62 Mn |
| Dec 31, 2023 | 10.76 Mn |
| Sep 30, 2023 | 10.90 Mn |
| Mar 31, 2018 | 3,940.00 |
| Dec 31, 2017 | 4,028.00 |
| Sep 30, 2017 | 4,117.00 |
| Jun 30, 2017 | 4,205.00 |
| Mar 31, 2017 | 4,293.00 |
| Dec 31, 2016 | 4,382.00 |
| Sep 30, 2016 | 42,555.00 |
| Jun 30, 2016 | 82,351.00 |
| Mar 31, 2016 | 123,944.00 |